lamotrigin arrow 50 mg disperzibilne tablete
arrow generics limited - lamotrigin - disperzibilna tableta - lamotrigin 50 mg / 1 tableta - lamotrigin
lamotrigin arrow 100 mg disperzibilne tablete
arrow generics limited - lamotrigin - disperzibilna tableta - lamotrigin 100 mg / 1 tableta - lamotrigin
lamotrigin arrow 5 mg disperzibilne tablete
arrow generics limited - lamotrigin - disperzibilna tableta - lamotrigin 5 mg / 1 tableta - lamotrigin
lamotrigin arrow 50 mg disperzibilne tablete
arrow generics limited - lamotrigin - disperzibilna tableta - lamotrigin 50 mg / 1 tableta - lamotrigin
lamotrigin arrow 200 mg disperzibilne tablete
arrow generics limited - lamotrigin - disperzibilna tableta - lamotrigin 200 mg / 1 tableta - lamotrigin
lamotrigin arrow 25 mg disperzibilne tablete
arrow generics limited - lamotrigin - disperzibilna tableta - lamotrigin 25 mg / 1 tableta - lamotrigin
anesia 20 mg/ml emulzija za injiciranje ali infundiranje
uab norameda - propofol - emulzija za injiciranje/infundiranje - propofol 20 mg / 1 ml - propofol
anesia 10 mg/ml emulzija za injiciranje ali infundiranje
uab norameda - propofol - emulzija za injiciranje/infundiranje - propofol 10 mg / 1 ml - propofol
anesia 10 mg/ml emulzija za injiciranje ali infundiranje
propofol - emulzija za injiciranje/infundiranje - propofol 10 mg / 1 ml - propofol
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragije - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.